about
Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapyThe role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience.Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients.Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasisNeoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastasesTailored radiotherapeutic strategies for disseminated uterine cervical cancer patientsTreatment outcome of patients with anaplastic thyroid cancer: a single center experienceMorphologic change of rectosigmoid colon using belly board and distended bladder protocolMulti-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients.Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer.Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South KoreaRole of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative RadiotherapyDo Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?Comparison of elective inguinal node irradiation techniques in anal cancer.Nutritional status of patients treated with radiotherapy as determined by subjective global assessment.Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after MastectomyThe location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancerNeoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.Postoperative irradiation after implant placement: A pilot study for prosthetic reconstruction.Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study.The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiationEarly hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis.Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II-III breast cancer? A multicentre retrospective study (KROG 12-05).Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.Microarray of DNA-protein complexes on poly-3-hydroxybutyrate surface for pathogen detection.Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.A New Clinical Trial of Neoadjuvant Chemotherapy Combined With Transoral Robotic Surgery and Customized Adjuvant Therapy for Patients With T3 or T4 Oropharyngeal Cancer.Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea.Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions.Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.Mechanical quality assurance using light field for linear accelerators with camera calibration.
P50
Q33922087-ECDDBF20-A3DF-4365-BF60-0E6E94F74542Q34137566-E49EEC13-B89A-4B0B-830D-AB39B56A4FE8Q34325443-97822587-C653-461E-A7AF-1671436A3AF7Q34325446-11A1D3CC-7025-441F-9B29-C05386F2A1A0Q35030263-C31570FF-50EA-4171-A902-E81794163D08Q35152348-A58B6215-5498-429F-A028-9D8F461786BDQ35206160-97658D30-FB4B-4D20-AA11-E21B59A52250Q35379790-E752B536-E2C7-497B-8424-91F2133D1D47Q35767404-375DF832-770A-48C5-8B72-EA36CBB4B809Q35824242-20AA2BA1-2691-411D-80D8-EC833DC101E2Q35824260-CB1C8EF0-1F1C-45F0-AEC1-20F4408A5AA5Q35867392-CE2BB0A3-5899-4FBD-9DF8-521599939DC2Q36166868-1BE6CE95-126E-4E3B-84E2-9551F796C7C8Q36187049-2CF8033B-8D2C-44CC-8D51-92FC29816587Q36194009-C65C2ECC-1E1B-40D9-B92C-38496B789489Q36196016-4AA30872-F7EF-4F81-ACD7-B1B6EF5F7ECCQ36395257-CB42D417-31C3-47AE-BDB6-6E937C70E05DQ36482404-C9458A98-C20E-4456-B280-47F134F1217CQ36786775-FB25A472-097E-42E0-BBCE-FFDB844642D3Q36832255-A3671794-8DB7-4703-B8A4-944465FD4BADQ37015364-424544BF-2C0D-48EE-8350-C48761294D75Q37092796-A1C56EDB-60D3-454B-A7B7-2E24B4D15574Q37097487-BEB771C2-133C-42C8-8C24-13755A80E061Q37097507-2E28E8AD-0BA8-4E27-A0B5-B2E1FE739672Q37398748-42702F58-9A92-4319-BA64-D3A9EA79FBE7Q37549480-CC762A5B-57D7-4F3F-B13D-1B685BE56D94Q37549514-3BDB0CD7-CF2F-43F4-B6ED-C9A1CCF5AA9DQ37551753-DA023072-E58A-40AC-A672-4624A6E65C5FQ37650634-F4532164-D729-4825-A07C-2BF7C0505AB0Q37900551-AFF9C524-E7F9-4544-9409-077DC93634AEQ38357895-F5D350F7-34C4-46A7-A9BE-039FE64D5B34Q38399134-C7F59AFC-30A4-4126-9958-9C2D20D0019BQ38656128-DB4F22D5-E062-49AB-AA06-A699C9A5D626Q38803935-6BD3AD2A-4BB7-4E29-9787-0278C1465863Q38917073-745494D7-6C5E-4342-945A-244939E93AA7Q39310478-A63CAD62-0138-4BD0-BEF5-C402D4A4AE06Q39543776-29621AF3-D7EE-44DA-AE81-436563D73775Q40011137-10772B39-EF2D-412A-8AD9-271F7ED2E055Q40296167-6F6867D4-9F95-4707-B85C-88F6D1FF8F01Q40349355-5951D4AC-DDB1-40BD-BF1A-6CBB9A47276E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ki Chang Keum
@ast
Ki Chang Keum
@en
Ki Chang Keum
@es
Ki Chang Keum
@nl
type
label
Ki Chang Keum
@ast
Ki Chang Keum
@en
Ki Chang Keum
@es
Ki Chang Keum
@nl
prefLabel
Ki Chang Keum
@ast
Ki Chang Keum
@en
Ki Chang Keum
@es
Ki Chang Keum
@nl
P106
P31
P496
0000-0003-4123-7998